Functional genomic landscapes of EGFR-mutant gliomas were elucidated by genome-wide piggyBac transposon mutagenesis and transcriptomics, identifying 281 known and novel cancer genes (tumor suppressors and oncogenes), with clinical relevance demonstrated by confirming corresponding human genetic alterations in patients. This evidence concerns the gene EGFR and neoplasm.